InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ZEVRA THERAPEUTICS, INC.

ZVRA Clue Score60
United States Fiscal year ends December CIK 0001434647 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Neil F. McFarlane
12 Oct 2026
President and CEO
Sold on a plan
20,000
$11.25
$224.95K
Rahsaan Thompson
14 Aug 2026
Chief Legal & Compliance
Sold on a plan
42,666
$11.13
$474.77K
Rahsaan Thompson
22 Jun 2026
Chief Legal & Compliance
Sold on a plan
34,557
$12.68
$438.30K
Rahsaan Thompson
11 May 2026
Chief Legal & Compliance
Sold on a plan
1,794
$11.30
$20.27K
Neil F. McFarlane
9 Feb 2026
President and CEO
Sold on a plan
14,625
$8.56
$125.19K
Joshua Schafer
3 Feb 2026
CCO
Sold on a plan
10,500
$9.19
$96.50K
Timothy J. Sangiovanni
3 Feb 2026
SVP, Finance & Corp Controller
Sold on a plan
3,000
$9.18
$27.55K
Neil F. McFarlane
2 Feb 2026
President and CEO
Sold on a plan
91,000
$9.38
$853.43K
Show all 15 transactions →

What was left out

Form 4 filings counted 24
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 5
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 754,713
History held since 17 Apr 2015